Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide |
| |
Authors: | Kaneto Hideaki Nakatani Yoshihisa Miyatsuka Takeshi Kawamori Dan Matsuoka Taka-aki Matsuhisa Munehide Kajimoto Yoshitaka Ichijo Hidenori Yamasaki Yoshimitsu Hori Masatsugu |
| |
Affiliation: | Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. kaneto@medone.med.osaka-u.ac.jp |
| |
Abstract: | The JNK pathway is known to be activated in several tissues in the diabetic state, and is possibly involved in the development of insulin resistance and suppression of insulin biosynthesis. Here we show a potential new therapy for diabetes using cell-permeable JNK-inhibitory peptide. Intraperitoneal administration of the peptide led to its transduction into various tissues in vivo, and this treatment markedly improved insulin resistance and ameliorated glucose tolerance in diabetic mice. These data indicate that the JNK pathway is critically involved in diabetes and that the cell-permeable JNK-inhibitory peptide may have promise as a new therapeutic agent for diabetes. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|